Cargando…

Persistent High Percentage of HLA-DR(+)CD38(high) CD8(+) T Cells Associated With Immune Disorder and Disease Severity of COVID-19

BACKGROUND: The global outbreak of coronavirus disease 2019 (COVID-19) has turned into a worldwide public health crisis and caused more than 100,000,000 severe cases. Progressive lymphopenia, especially in T cells, was a prominent clinical feature of severe COVID-19. Activated HLA-DR(+)CD38(+) CD8(+...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Juan, Wei, Lirong, Li, Guoli, Hua, Mingxi, Sun, Yao, Wang, Di, Han, Kai, Yan, Yonghong, Song, Chuan, Song, Rui, Zhang, Henghui, Han, Junyan, Liu, Jingyuan, Kong, Yaxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458852/ https://www.ncbi.nlm.nih.gov/pubmed/34567001 http://dx.doi.org/10.3389/fimmu.2021.735125

Ejemplares similares

Clonally diverse CD38(+)HLA-DR(+)CD8(+) T cells persist during fatal H7N9 disease
por: Wang, Zhongfang, et al.
Publicado: (2018)

Potential Role for HIV-Specific CD38(−)/HLA-DR(+) CD8(+) T Cells in Viral Suppression and Cytotoxicity in HIV Controllers
por: Hua, Stéphane, et al.
Publicado: (2014)

Level of CD8 T Lymphocytes Activation in HIV-Infected Pregnant Women: In the Context of CD38 and HLA-DR Activation Markers
por: Musyoki, Stanslaus, et al.
Publicado: (2014)

Functional Change of Effector Tumor-Infiltrating CCR5(+)CD38(+)HLA-DR(+)CD8(+) T Cells in Glioma Microenvironment
por: Chen, Pin-Yuan, et al.
Publicado: (2019)

Storm of soluble immune checkpoints associated with disease severity of COVID-19
por: Kong, Yaxian, et al.
Publicado: (2020)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

The potential role of HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppressive activity and cytotoxicity in HIV controllers
por: Hua, Stéphane, et al.
Publicado: (2014)

Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment
por: Díaz-Fernández, Sergio, et al.
Publicado: (2022)

Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls
por: Pereira-Manfro, Wânia Ferraz, et al.
Publicado: (2023)

HLA-DR polymorphism affects the interaction with CD4
Publicado: (1995)

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

VEGF-D: a novel biomarker for detection of COVID-19 progression
por: Kong, Yaxian, et al.
Publicado: (2020)

Percentage of Peripheral CD19+CD24hiCD38hi Regulatory B Cells in Neonatal Sepsis Patients and Its Functional Implication
por: Pan, Xiao, et al.
Publicado: (2016)

Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy
por: Lee, Eunok, et al.
Publicado: (2019)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

Scolopendra subspinipes mutilans L. Koch Ameliorates Rheumatic Heart Disease by Affecting Relative Percentages of CD4(+)CD25(+)FoxP3 Treg and CD4(+)IL17 T Cells
por: Jiang, Tiechao, et al.
Publicado: (2019)

Highly Active Antiretroviral Therapy (HAART)-Related Hypertriglyceridemia Is Associated With Failure of Recovery of CD14(low)CD16(+) Monocyte Subsets in AIDS Patients
por: Han, Junyan, et al.
Publicado: (2015)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2015)

Factors associated with the elevated percentage of CD4CD69 T cells in maintained hemodialysis patients
por: Chen, Rongyi, et al.
Publicado: (2017)

Elevated percentage of HLA-DR(+) and ICAM-1(+) conjunctival epithelial cells in active Graves’ orbitopathy
por: Pawlowski, P., et al.
Publicado: (2014)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

CD4(+)CD38(+) central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART
por: Song, Cheng-Bo, et al.
Publicado: (2020)

HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers
por: Joher, Nizar, et al.
Publicado: (2021)

Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients
por: Kubysheva, Nailya, et al.
Publicado: (2017)

High Levels of CD244 Rather Than CD160 Associate With CD8(+) T-Cell Aging
por: Wang, Xinyue, et al.
Publicado: (2022)

A decrease in PPD specific CD4 T cell CD38 and HLA-DR expression in pulmonary tuberculosis patients after 8 weeks of therapy correlates with successful anti-tuberculosis treatment
por: Priyanto, Herry, et al.
Publicado: (2021)

Percentage and function of CD4(+)CD25(+) regulatory T cells in patients with hyperthyroidism
por: Jiang, Ting-Jun, et al.
Publicado: (2018)

PDK1/mTOR Signaling in Myeloid Cells Differentially Regulates the Early and Late Stages of Sepsis
por: Du, Juan, et al.
Publicado: (2020)

Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome
por: Gatti, Arianna, et al.
Publicado: (2023)

Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4(+) T Lymphocytes
por: Chaux, Pascal, et al.
Publicado: (1999)

Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects
por: Mondatore, Debora, et al.
Publicado: (2022)

Expression of CD1a, CD207, CD11b, CD11c, CD103, and HLA-DR receptors on the surface of dendritic cells in the skin of patients with atopic dermatitis
por: Ścibior, Kinga, et al.
Publicado: (2017)

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells
por: Rohn, Hana, et al.
Publicado: (2022)

Decreased percentage of CD4(+)Foxp3(+)TGF-β(+) and increased percentage of CD4(+)IL-17(+) cells in bronchoalveolar lavage of asthmatics
por: Barczyk, Adam, et al.
Publicado: (2014)

Fatal COVID-19 is Associated with Reduced HLA-DR, CD123 or CD11c Expression on Circulating Dendritic Cells
por: Hasan, Amal, et al.
Publicado: (2022)

Elevated Percentage of CD3(+) T-Cells and CD4(+)/CD8(+) Ratios in Multiple System Atrophy Patients
por: Cao, Bei, et al.
Publicado: (2020)

Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33(+)CD11b(+)HLA-DR(+) Cells: A Cross-Sectional Study
por: Meng, Zhefeng, et al.
Publicado: (2016)

Poor Immune Reconstitution in HIV-Infected Patients Associates with High Percentage of Regulatory CD4(+) T Cells
por: Horta, Ana, et al.
Publicado: (2013)

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_0rtgakp2neh5o0f8ol8at08md0